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Introduction
Polarized mammalian epithelia form tight junctions between 
adjacent cells to regulate transepithelial permeability (gate func-
tion) and to separate the distinct apical and basolateral domains 
(fence function; Matter and Balda, 2003). The complexity of 
tight junction functions is refl  ected in the large number of associ-
ated signaling and regulatory molecules, including the polarity 
proteins Par-3, Par-6, and atypical PKC (aPKC; Macara, 2004). 
Tight junctions are attached to a cortical actin network through 
several linker proteins, and modulation of the actin cytoskele-
ton has a profound impact on both the assembly and functions of 
tight junctions. Despite intensive studies on the roles of polarity 
proteins in controlling polarization and cell junction formation 
(for review see Roh and Margolis, 2003; Munro, 2006), relatively 
little is known about how they interact with other cellular com-
ponents to orchestrate these events. We have recently shown by 
RNA interference (RNAi) that Par-3 is essential for the proper 
assembly of tight junctions in mammalian epithelial cells (Chen 
and Macara, 2005) partially through its interaction with Tiam1 to 
spatially restrict the activity of Rac. We now show that Par-3 can 
also regulate cofi  lin phosphorylation by LIM kinase 2 (LIMK2).
Cofi  lin binds to and severs actin fi  laments, and it is crucial 
for numerous fundamental cellular processes such as migration, 
cytokinesis, and phagocytosis (Bamburg, 1999). Cofi  lin activity 
is inhibited by a single phosphorylation on Ser3, which is medi-
ated by LIMKs or testicular protein kinases. Dephosphorylation 
is executed by protein phosphatases such as Slingshot (Niwa 
et al., 2002). LIMKs contain two LIM domains and a PDZ do-
main (Okano et al., 1995) and are activated by members of the 
Rho family of small GTPases. Recently, cofi  lin-mediated actin 
turnover has been shown to contribute to the disassembly of the 
apical junctional complex, which is induced in epithelial cells 
by calcium depletion (Ivanov et al., 2004). However, it has not 
been implicated in tight junction assembly.
Results and discussion
Given the close connections between actin   reorganization and 
tight junction assembly, we examined the effects of reduced 
Par-3 expression on the phosphorylation of   cofi  lin. The speci-
fi  city of Par-3 suppression by RNAi has been confi  rmed previ-
ously (Chen and Macara, 2005). Depletion of Par-3 caused a 
substantial increase in cofi  lin Ser3 phosphorylation (Fig. 1 A 
and Fig. S1 A, available at http://www.jcb.org/cgi/ content/full/
jcb.200510061/DC1). In contrast, depletion of the tight junction 
protein occludin had only a small effect on phospho-cofi  lin 
levels (Fig. S1 B). Epithelial (E)   cadherin knockdown (KD) 
also resulted in   elevated levels of phospho-cofi  lin (Fig. S1 B), 
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but depletion of Par-3 did not   affect E-cadherin levels or dis-
rupt adherens junctions under normal calcium conditions and 
only had minor effects on adherens junction assembly during 
calcium switch (Chen and Macara, 2005). Moreover, when 
MDCK cells were subjected to calcium depletion overnight 
to disrupt all cell–cell junctions, the phospho-cofi  lin levels in 
Par-3–  depleted cells were still higher than in control cells (Fig. 
1 B, LCM), indicating that Par-3 can regulate phospho-cofi  lin 
levels independently of cell junction status and extracellular cal-
cium levels. In addition, a double KD of Par-3 and E-cadherin 
led to an additive increase in phospho-cofi  lin compared with 
that achieved by a single KD of Par-3 or E-cadherin (Fig. S1 C), 
further suggesting that Par-3 and E-cadherin regulates cofi  lin 
phosphorylation through distinct mechanisms. Transient ex-
pression of human Par-3c, which is not recognized by the short 
hairpin RNA (shRNA) targeting canine Par-3, partially reversed 
the increase in phospho-cofi  lin (Fig. 1 B), supporting the argu-
ment that the increased phospho-cofi  lin is caused by Par-3 de-
pletion rather than by off-target effects. Par-3c is a splice variant 
that lacks the aPKC-binding site (Gao et al., 2002), suggesting 
that the ability of Par-3 to regulate cofi  lin phosphorylation does 
not involve aPKC.
To determine whether regulation of phospho-cofi  lin by 
Par-3 is conserved across different cell types, we suppressed the 
expression of endogenous Par-3 in HeLa cells and found that 
cofi  lin phosphorylation was also enhanced after Par-3 depletion 
(Fig. 1 C). Similarly, depletion of endogenous Par-3 in MCF-7 
breast carcinoma cells also markedly elevated the pool of 
 phospho-cofi  lin (Fig. 1 D). Neuregulin (NRG)-1β treatment of 
MCF-7 cells activated the cofi  lin-specifi  c phosphatase Sling-
shot (Nagata-Ohashi et al., 2004) and completely blocked the 
increase in phospho-cofi  lin in Par-3–depleted cells (Fig. 1 D), 
indicating that the loss of Par-3 does not interfere with the acti-
vation of Slingshot. These data suggest that Par-3 is generally 
involved in down-regulating cofi  lin phosphorylation.
Because the depletion of Par-3 results in phosphorylation 
of cofi  lin and its inactivation, we investigated whether reduced 
cofi  lin activity might contribute to the defects in tight junction 
assembly caused by Par-3 depletion. Using the transmembrane 
protein occludin as a marker, we observed, as reported previ-
ously, that MDCK cells lacking Par-3 had disrupted tight junc-
tions for many hours after a calcium switch (Fig. 2 A; Chen and 
Macara, 2005). However, the normal cortical distribution of oc-
cludin was partially rescued at later stages of junction assembly 
by transient expression of a phosphorylation-defective, consti-
tutively active cofi  lin mutant (S3A; Fig. 2 A). Quantifi  cation of 
the mean length per cell of occludin at cell–cell contacts con-
fi  rmed the signifi  cance of the enhanced cortical localization of 
occludin (Fig. 2 B). Importantly, the expression of cofi  lin S3A 
did not affect the effi  ciency of Par-3 KD (Fig. 2 C). As shown 
previously, the loss of Par-3 substantially delayed the develop-
ment of transepithelial electrical resistance (TER) after calcium 
readdition, and this was partially reversed by the expression of 
cofi  lin S3A (Fig. 2 D; Chen and Macara, 2005). Silencing of 
Figure 1.  Loss of Par-3 leads to elevated levels of phospho-coﬁ  lin. (A) MDCK cells were transfected with control or pSUPER–Par-3 (Par-3 KD) to sup-
press Par-3 expression followed by calcium switch. HCM, high calcium medium. Total cell lysates were analyzed by immunoblotting. (B) Ectopic   
Par-3c reduces phospho-coﬁ  lin levels in Par-3–depleted cells. A construct encoding human Par-3c was cotransfected with pSUPER–Par-3 into MDCK 
cells followed by calcium switch and Western blot analysis of total cell lysates. Numbers indicate relative levels of phospho-coﬁ  lin normalized against 
the total coﬁ   lin level. LCM, low calcium medium. (C) Depletion of endogenous Par-3 in HeLa cells increases phospho-coﬁ   lin levels. HeLa cells 
were   transfected with human Par-3–speciﬁ  c (Par-3 KD) or control siRNAs. Cell lysates were prepared 48 and 72 h later and blotted with indicated 
antibodies. (D) NRG treatment abolishes the increase in phospho-coﬁ  lin in Par-3–depleted MCF-7 cells. 1 d after transfection with Par-3–speciﬁ  c 
or   control   siRNAs, MCF-7 cells were serum starved overnight followed by 45 min of treatment with 50 ng/ml NRG in serum-free medium before 
cells were lysed.PAR-3 INHIBITS LIMK2   • CHEN AND MACARA  673
cofi  lin expression alone did not disrupt tight junctions, however, 
suggesting that cofi  lin activity is not a limiting regulator of 
junction assembly (Fig. S1, E–G). Altogether, these results sug-
gest that cofi  lin activity contributes to tight junction formation 
during epithelial cell polarization and that one of the functions 
of Par-3 is to prevent inappropriate cofi  lin phosphorylation.
We have shown previously that Par-3 binds to Tiam1 to 
down-regulate Rac activity (Chen and Macara, 2005). However, 
a double KD of Par-3 and Tiam1 had no effect on the augmented 
phospho-cofi  lin levels induced by Par-3 suppression (Fig. S1 D). 
Furthermore, the expression of a constitutively active fragment 
of Tiam1 (Tiam1 C1199; Chen and Macara, 2005) did not 
 elevate  phospho-cofi  lin levels (Fig. S1 D), supporting the idea 
that the elevated phospho-cofi  lin in Par-3 KD cells is indepen-
dent of misregulated Tiam1 activity. Interestingly, cofi  lin S3A 
expression did not further improve the TER establishment in 
Par-3 and Tiam1 double KD cells (Fig. S1 H), suggesting that 
cofi  lin   activity and the Tiam1–Rac pathway may regulate simi-
lar aspects or stages of tight junction assembly.
We next asked whether Par-3 might directly or indirectly 
regulate the activities of LIMKs or phosphatases to infl  uence co-
fi   lin phosphorylation. LIMKs are activated by Rho small 
  GTPases through their downstream effectors Rho-associated 
  kinase (ROCK) and p21-activated kinase (Edwards et al., 1999; 
Sumi et al., 2001). No specifi  c binding of Par-3 to the Slingshot 
phosphatase was detected (unpublished data), which is consis-
tent with our observation that Slingshot activation is not altered 
by the loss of Par-3 (Fig. 1 D). However, recombinant Par-3 frag-
ments (Par-3c-B and Par-3c-D) specifi  cally pulled down LIMK2 
but not LIMK1 from COS cell lysates (Fig. 3 B).   Furthermore, 
the COOH terminus of Par-3 (Par-3c-E) alone coimmunoprecip-
itated LIMK2 just as effi  ciently as a longer fragment of Par-3 
(Par-3c-D; Fig. 3 C), suggesting that the COOH terminus of   
Par-3 is suffi   cient to mediate the interaction with LIMK2. 
In contrast, another PDZ domain–containing polarity protein, 
Pals1, did not coimmunoprecipitate LIMK2. When endogenous 
LIMK2 from MDCK cells was immunoprecipitated, an associa-
tion of endogenous Par-3 with LIMK2 was detected (Fig. 3 D). 
These data demonstrate that Par-3 and LIMK2 interact in vivo.
To further dissect the region of LIMK2 that is involved in 
its interaction with Par-3, deletion fragments of LIMK2 were 
tested for their abilities to coimmunoprecipitate the COOH ter-
minus of Par-3 (Fig. 3 E). Deletion of the entire NH2-terminal 
half of LIMK2 (LIMK2 ∆N) or of the two LIM domains 
Figure 2.  Expression of nonphosphorylatable coﬁ  lin S3A mutant promotes tight junction assembly in Par-3 KD MDCK cells. (A) MDCK cells were trans-
fected with control, pSUPER–Par-3 (Par-3 KD), or pSUPER–Par-3 together with a construct expressing coﬁ  lin S3A (+coﬁ  lin S3A). Cells were subjected to cal-
cium switch and stained for occludin at various times after calcium readdition. (B) Quantiﬁ  cation of occludin cortical localization after calcium readdition. 
Asterisks denote a signiﬁ  cant difference from Par-3 KD cells (P < 0.05) by t test. 6-h time point: control, n = 6; Par-3 KD, n = 7; coﬁ  lin S3A, n = 6. 
7-h time point: control, n = 6; Par-3 KD, n = 7; coﬁ  lin S3A, n = 7. (C) Western blot analysis of total cell lysates from A. White lines indicate that interven-
ing lanes have been spliced out. (D) Coﬁ  lin S3A expression partially rescues the development of transepithelial electrical resistance (TER) in Par-3 KD MDCK 
cells during calcium switch. MDCK cells were transfected with indicated constructs, and the kinetics of TER establishment was monitored for 13 h after the 
readdition of calcium. Each value is the mean of triplicate measurements (n = 3). Error bars represent SD.JCB • VOLUME 172 • NUMBER 5 • 2006  674
(LIMK2 ∆LIM) severely abrogated association with the Par-3 
COOH terminus, indicating that the LIM domains are required 
for the interaction. In contrast, LIMK2 ∆C or a kinase-dead 
mutant of LIMK2 was able to associate with Par-3 (Fig. 3 E 
and Fig. S2 A, availableat http://www.jcb.org/cgi/content/full/
jcb.200510061/DC1). To examine whether Par-3 fragments can 
bind to the NH2 terminus of LIMK2 in vitro, recombinant Par-3 
fragments immobilized on beads were incubated with GST–
LIMK2 ∆C or with GST-Rac as a negative control (Fig. 3 F). 
GST–LIMK2 ∆C interacted very weakly with the Par-3c-A 
fragment, but it showed more robust interaction with the 
Par-3c-B and Par-3c-D fragments, which is in agreement with 
the pull-down experiments.
LIMK2 can be activated by ROCK downstream of RhoA 
(Sumi et al., 2001). A specifi  c ROCK inhibitor H-1152 greatly 
reduced the phospho-cofi  lin level in Par-3 KD MDCK cells 
(Fig. 4 A), supporting the involvement of LIMK2 in cofi  lin 
phosphorylation. To confi  rm that endogenous LIMK2 mediates 
cofi  lin phosphorylation in Par-3–depleted cells, we partially 
suppressed the expression of LIMK2 in MDCK cells by RNAi 
without affecting the total levels of Par-3 and cofi  lin (Fig. 4 B). 
Double KD of both Par-3 and LIMK2 inhibited the increase 
in phospho-cofi  lin caused by Par-3 depletion (Fig. 4 C), sug-
gesting that LIMK2 is important for increasing phospho-cofi  lin 
levels after Par-3 depletion. Consistent with the reduction in 
phospho-cofi  lin level, the suppression of both Par-3 and LIMK2 
also promoted the assembly of tight junctions after a calcium 
switch, as monitored by the improved localization of occludin 
to cell–cell borders (Fig. 4, D and E) and by the small but repro-
ducible enhancement in TER establishment (Fig. S2 C).
RhoA activity is not altered in Par-3 KD cells (Chen and 
Macara, 2005), and we could not detect any interaction between 
Figure 3.  Par-3 interacts with LIMK2 in vivo and in vitro. (A) Schematic diagrams of Par-3, LIMK2, and their various deletion fragments. Amino acid residue 
numbers are shown. Par-3c is a splice variant that lacks the aPKC-binding site. (B) Association of LIMK2 but not LIMK1 with recombinant Par-3 fragments.   
S-tagged Par-3 fragments immobilized on beads were incubated with COS cell lysates expressing Flag-tagged LIMK1 or LIMK2. Bound proteins were 
  analyzed by Western blotting. (C) The COOH terminus of Par-3 is sufﬁ  cient to associate with LIMK2. COS cells transfected with the indicated constructs 
were lysed, and the myc-tagged Par-3 fragments and Pals1 were immunoprecipitated by an anti-myc antibody. The associated LIMK2 was detected with 
an anti-HA antibody. Arrowhead points to LIMK2-HA. IP, immunoprecipitation. (D) Association of endogenous Par-3 and LIMK2 in MDCK cells. Endogenous 
LIMK2 was immunoprecipitated with an anti-LIMK2 antibody. Control immunoprecipitations were performed with anti-GFP and anti–β-catenin antibodies. 
(E) The NH2-terminal region of LIMK2 is required for association with the Par-3 COOH terminus. COS cells were transiently transfected with constructs ex-
pressing the COOH terminus of Par-3 (Par-3c-E) together with various LIMK2 deletion fragments. LIMK2 fragments were immunoprecipitated with an anti-HA 
antibody, and the associated Par-3c-E fragment was detected with an anti-myc antibody. Asterisks indicate LIMK2 fragments. (F) Binding of LIMK2 NH2 ter-
minus to Par-3 fragments in vitro. GST–LIMK2 ∆C or GST-Rac was incubated with S-tagged Par-3 fragments immobilized on beads, and their interactions 
were analyzed by Western blotting. Asterisks indicate breakdown products. Arrowhead points to nonspeciﬁ  cally associated GST-Rac. White lines indicate 
that intervening lanes have been spliced out.PAR-3 INHIBITS LIMK2   • CHEN AND MACARA  675
Par-3 and ROCK (Fig. S2 B). The ability of Par-3 to interact with 
LIMK2 suggests that Par-3 is acting directly on LIMK2. Inter-
estingly, cells lacking Par-3 showed a small increase in the level 
of phosphorylation on Thr505 of LIMK2 (Fig. S3 A, available 
at http://www.jcb.org/cgi/content/full/jcb.200510061/DC1). 
Phosphorylation at this site is mediated by ROCK and leads to 
LIMK2 activation (Sumi et al., 2001). Therefore, Par-3 might 
be involved in negatively regulating LIMK2 activation by 
ROCK in vivo.
We next examined whether Par-3 can mediate the inhi-
bition of LIMK2 kinase activity in vitro. Immunoprecipitated 
LIMK2 specifi  cally phosphorylated GST-cofi  lin, and the pres-
ence of Par-3b inhibited this activity (Fig. 5 A). Par-3b was 
also phosphorylated during the kinase assay, which was likely 
caused by endogenous aPKC associated with Par-3b (Gao et al., 
2002). However, the Par-3c splice variant also inhibited the ki-
nase activity of LIMK2 (Fig. 5 B). This variant does not bind to 
aPKC (Gao et al., 2002), and it was minimally phosphorylated 
compared with Par-3b. To test the specifi  city of the inhibition, 
LIMK1 was used, and its activity was not inhibited by Par-3 
(Fig. S3 B). Moreover, when we replaced Par-3 with another 
PDZ domain protein, Pals1, no inhibition of LIMK2 activity 
was observed (Fig. S3 C).
To determine whether Par-3 can inhibit cofi  lin phosphory-
lation in vivo, Par-3c was transiently expressed in COS cells 
followed by treatment with lysophosphatidic acid (LPA), which 
activates the Rho–ROCK–LIMK2 pathway (Fig. 5 C). Overex-
pression of Par-3c decreased the basal phospho-cofi  lin level 
(0 min) and inhibited the increase in cofi  lin phosphorylation in-
duced by LPA. Together, our data suggest that Par-3 binding to 
LIMK2 mediates the inhibition of LIMK2 activity and the 
down-regulation of cofi  lin phosphorylation.
LIMK1 and 2 share similar domain structures and have 
50% overall amino acid identity (Okano et al., 1995), but they 
are regulated by distinct mechanisms. LIMK1 is activated spe-
cifi  cally by p21-activated kinase and is inhibited by association 
with bone morphogenetic protein type II receptor, which binds 
to the NH2-terminal region of LIMK1 (Foletta et al., 2003). 
Figure 4.  Suppressing LIMK2 expression promotes tight junction assembly in Par-3 KD MDCK cells. (A) ROCK activity is required for the elevated phospho-
coﬁ  lin in Par-3–depleted cells. Control or Par-3 KD MDCK cells were subjected to calcium switch and treated with 10 μM H-1152 for indicated times after 
the readdition of calcium. Cells without calcium switch (HCM) were treated with H-1152 for 1 h. Total cell lysates were analyzed by immunoblotting. 
(B) Suppression of LIMK2 level in MDCK cells. MDCK cells were transfected with control vector or two different pSUPER-LIMK2 (LIMK2 KD) constructs targeting 
  distinct regions of canine LIMK2 mRNA. Total cell lysates were probed with the indicated antibodies. pSUPER–LIMK2 #2 reduced LIMK2 levels and was 
used for subsequent studies. (C) Double KD of LIMK2 and Par-3 blocks the increase in phospho-coﬁ  lin levels. MDCK cells were transfected with control vec-
tor, pSUPER–Par-3 (Par-3 KD) alone, or pSUPER–Par-3 together with pSUPER-LIMK2 (double KD). Total cell lysates were probed with the indicated anti-
bodies. Numbers indicate relative levels of phospho-coﬁ  lin normalized against the total coﬁ  lin level. (D) Double KD of LIMK2 and Par-3 partially rescues 
occludin localization during calcium switch. MDCK cells were transfected as in C followed by calcium switch and staining for occludin at various times after 
calcium readdition. (E) Quantiﬁ  cation of occludin cortical localization after the readdition of calcium. Asterisks denote signiﬁ  cant differences from Par-3 
KD cells (P < 0.05) by t test. Control, n = 5; Par-3 KD, n = 6; Par-3/LIMK2 KD, n = 6. Error bars represent SD.JCB • VOLUME 172 • NUMBER 5 • 2006  676
LIMK2 is activated specifi  cally by ROCK and, as we show 
here, is inhibited by association through its NH2-terminal region 
with Par-3. The two kinases also exhibit different tissue distri-
butions, with LIMK1 highly expressed in the brain and LIMK2 
broadly expressed in the epithelia of nonneuronal tissues (Mori 
et al., 1997), which is consistent with a role for LIMK2 in epi-
thelial polarization.
Although Par-3 is known to be a key regulator of epithe-
lial polarization, its molecular actions have remained elusive. 
We have now identifi  ed a novel function for Par-3 in the regula-
tion of LIMK2, which phosphorylates and inactivates cofi  lin. 
Depletion of Par-3 leads to elevated cofi  lin phosphorylation, 
and the restoration of cofi  lin activity by either active cofi  lin 
mutant or double KD of Par-3 and LIMK2 partially rescues 
tight junction assembly, indicating that the suppression of co-
fi  lin   phosphorylation by Par-3 plays a positive role in junction 
 assembly. Although it is possible that other indirect mechanisms 
contribute to the increase in phospho-cofi  lin after Par-3 KD, our 
data strongly suggest that Par-3 is directly involved in regu lating 
cofi  lin phosphorylation through its interaction with LIMK2. 
  Together with our previous fi  nding that Par-3 regulates Rac ac-
tivity through its interaction with Tiam1 (Chen and Macara, 2005), 
our current study suggests a possible role for Par-3 in modu-
lating actin dynamics to facilitate junction assembly and polar-
ization. On the other hand, actin organization is required for the 
correct localization of Bazooka (the Drosophila melanogaster 
homologue of Par-3) in Drosophila embryonic epithelia (Harris 
and Peifer, 2005). We propose that one of the functions of Par-3 
is to coordinate and fi  ne-tune the actin remodeling processes 
associated with junction assembly through its abilities to inter-
act with and regulate multiple signaling pathways that control 
actin reorganization. It will be interesting to examine whether 
this mechanism of Par-3–directed cofi   lin activation is used 
in other cellular processes that require polarization, such as 
cell migration.
Materials and methods
Constructs
The following constructs have been described previously: myc and HA-
tagged full-length Par-3b, Par-3c and Par-3c fragments (Par-3c-A, Par-3c-B, 
Par-3c-D, and Par-3c-E), and S-tagged Par-3c fragments (Joberty et al., 
2000; Chen and Macara, 2005). Human coﬁ   lin-1 was generated by 
PCR from a human kidney cDNA library (CLONTECH Laboratories, Inc.) 
and cloned into the pKH3 and the pGEX-2T vectors. Coﬁ  lin S3A was cre-
ated using the QuikChange Site-Directed Mutagenesis Kit (Stratagene). 
Figure 5.  Par-3 negatively regulates LIMK2 activity. (A) Par-3 inhibits LIMK2 kinase activity in vitro. HA-tagged LIMK2 or Par-3b was expressed in COS 
cells and immunoprecipitated. The immunocomplexes were subjected to in vitro kinase assays using GST-coﬁ  lin as the substrate or GST-Rac as a control. 
Coomassie brilliant blue (CBB) staining showed equal amounts of LIMK2 and GST-coﬁ  lin in the assays. (B) aPKC is not required for Par-3 to inhibit LIMK2 
activity in vitro. HA-tagged Par-3c variant, which does not bind to aPKC, was used in the kinase assay together with Par-3b. (C) Ectopic Par-3 inhibits coﬁ  lin 
phosphorylation after LPA treatment. Control COS cells or cells expressing Par-3c were serum starved for 4 h and brieﬂ  y treated with 5 μM LPA for indicated 
times. Total cell lysates were probed with speciﬁ  ed antibodies. Numbers on the bottom of the blot indicate relative levels of phospho-coﬁ  lin normalized 
against the total coﬁ  lin level. Graph is representative of two independent experiments.PAR-3 INHIBITS LIMK2   • CHEN AND MACARA  677
Human Slingshot in pcDNA3.1/myc-His was a gift from T. Uemura 
(Kyoto University, Kyoto, Japan). Flag-tagged LIMK1 in pEF-BOS was a gift 
from O. Bernard (The Walter and Eliza Hall Institute of Medical Research,
Victoria,   Australia). HA-tagged full-length rat LIMK2 and the LIMK2 kinase-
dead mutant in pcDNA3 were gifts from T. Nakamura (Osaka University, 
Osaka, Japan). LIMK2 deletion fragments were generated by PCR and 
cloned into pKH3 and pGEX-2T. ROCK KD-IA construct was a gift from 
S. Narumiya (Kyoto University, Kyoto, Japan). Tiam1 C1199 was provided 
by J.G. Collard (Netherlands Cancer Institute, Amsterdam, Netherlands).
Cell culture and transfection
MDCK, COS-7, HeLa, and MCF-7 cells were grown in DME supplemented 
with 10% calf serum, 100 U ml
-1 penicillin, and 100 U ml
-1 streptomycin 
  (Invitrogen). For transfection of MDCK cells, 2–4 μg DNA was introduced 
into 2–4 × 10
6 cells by Nucleofection (Amaxa) according to the manufac-
turer’s recommendations. Transfection efﬁ   ciency was generally >70%. 
For transfection with pSUPER constructs, enhanced YFP was coexpressed 
as a marker for transfected cells. Experiments were performed 2–3 d after 
transfection. COS-7 cells were transiently transfected using the calcium 
phosphate method.
RNAi
For RNAi in MDCK cells, pSUPER constructs expressing gene-speciﬁ  c 
shRNA were introduced into MDCK cells by Nucleofection. Generation 
of pSUPER constructs expressing shRNA targeting canine Par-3 or Tiam1 
has been described previously (Chen and Macara, 2005). The target 
sequences for other pSUPER constructs are as follows: canine occludin, 
A  G  A  G  G  A  A  T  T  A  T  T  G  C  A  A  G  C  A  ; canine E-cadherin, G T  C  T  A  A  C  A  G  G  G  A  C  A  A-
A  G  A  A  ; canine LIMK2, T  G  T  T  G  A  C  A  G  A  G  T  A  C  A  T  C  G  A  ; canine coﬁ  lin-1 #1, 
G  G  A  T  C  A  A  G  C  A  T  G  A  G  T  T  A  C  A  ; and canine coﬁ   lin-1 #4, A  G  A  T  C  C  T  G  G-
T    A    G    G  T  G  A  T  G  T  . Empty pSUPER vector or a pSUPER construct targeted 
against luciferase was used as a negative control. To silence Par-3 in HeLa 
and MCF-7 cells, a pool of four siRNA duplexes (SMARTpool reagent 
M-015602-00) was purchased from Dharmacon. As a negative control, 
we used a siCONTROL nontargeting siRNA. HeLa and MCF-7 cells were 
transfected using Oligofectamine and LipofectAMINE 2000 (Invitrogen), 
respectively. Cells were processed 48 or 72 h after transfection.
Calcium switch, immunoﬂ  uorescence, and quantiﬁ  cation of occludin length
Calcium switch experiments were performed as described previously (Chen 
and Macara, 2005). To detect occludin and YFP, cells were washed and ﬁ  xed 
in 1:1 methanol/acetone (vol/vol) for 3 min at −20°C. After washing with 
PBS, cells were blocked with 5% BSA in PBS for 25 min and incubated with 
primary and secondary antibodies. Primary antibodies were monoclonal anti-
occludin (Zymed Laboratories) and rabbit anti-GFP (Invitrogen). Secondary 
antibodies were AlexaFluor-conjugated goat anti–mouse and goat anti–rabbit 
antibodies (Invitrogen). AlexaFluor594-conjugated phalloidin was obtained 
from Invitrogen. Coverslips were mounted on slides, and images were ob-
tained and processed as previously described (Joberty et al., 2000).
To quantify the mean occludin length per cell, six to seven ﬁ  elds of 
cells with similar density were randomly selected from each coverslip, and 
the total length of occludin at cell junctions in each ﬁ  eld was measured 
  using the measurement tool in Openlab (Improvision). Only ﬁ  elds  with 
>70% transfected cells (as determined by YFP expression) were measured. 
Cell numbers were counted for each ﬁ  eld by DAPI staining, and the mean 
occludin length per cell on each ﬁ  eld was calculated (Chen and Macara, 
2005). Between 300 and 500 cells were counted for each coverslip. Each 
bar represents the mean value from all of the ﬁ  elds on each coverslip. 
  Statistical analysis was performed using a two-tailed t test.
Imaging
Epiﬂ   uorescence images were collected using an inverted microscope 
(Eclipse T200; Nikon) equipped with a 60× NA 1.2 plan Achromatic 
  water immersion lens (Nikon) and a charge-coupled device camera (Orca 
C4742-95-12NRB; Hamamatsu). Images were collected at a 12-bit depth 
and 1,024 × 1,280 pixel resolution with 1 × 1 binning using Openlab 
4.0 software (Improvision). Images were converted to eight-bit TIFF ﬁ  les 
and processed in Photoshop 7.0 (Adobe) to increase the gray scale range 
and to reduce haze using an unsharp mask.
TER measurements
After transfection, 6.6 × 10
5 MDCK II cells were plated into polycarbonate 
Transwell TM ﬁ  lters  (0.4-μm pore size and 12-mm diameter; Corning 
  Costar). 2 d later, cells were changed into low calcium medium (LCM) for 
18–20 h before being switched back to normal growth medium (high 
calcium medium [HCM]). TER was measured with an Epithelial Voltohmmeter 
(EVOM; World Precision Instruments). TER values were calculated by sub-
tracting the blank value from an empty ﬁ  lter with HCM and were expressed 
in ohm.cm
2. Three parallel ﬁ  lters from each transfection were measured for 
each time point.
Immunoprecipitation, Western blot, pull-down assays, and in vitro 
binding assays
Immunoprecipitation from transiently transfected COS-7 cells was performed 
as previously described (Chen and Macara, 2005). Anti-HA antibody 12CA5 
or anti-myc antibody 9E10 was used. To immunoprecipitate endogenous 
complexes of Par-3 and LIMK2 from MDCK cells, polyclonal anti-GFP antibody 
(Invitrogen), polyclonal anti-LIMK2 antibody (Santa Cruz Biotechnology, Inc.), 
and monoclonal anti–β-catenin antibody (BD Biosciences) were used.
To detect proteins by Western blotting, the following primary anti-
bodies were used: 12CA5 and 9E10 antibodies; polyclonal anti–Par-3 
(Upstate Biotechnology); monoclonal anti-Ran (BD Biosciences); polyclonal 
anti-LIMK2 (Santa Cruz Biotechnology, Inc.); polyclonal anti-coﬁ  lin, 
  antiphospho-coﬁ  lin (Ser3), and antiphospho-LIMK2 (Thr505; Cell Signal-
ing Technology); anti-destrin/actin-deploymerizing factor (Sigma-Aldrich); 
and HRP-conjugated S protein (Novagen). The ROCK inhibitor H-1152 
(Calbiochem) was used at 10 μM. Cells were pretreated for 30 min in 
LCM and switched to HCM with H-1152 for indicated times. NRG-1β 
  (Research Diagnostics) was used at 50 ng/ml. Densitometry analysis was 
performed using ImageJ software (National Institutes of Health) or the Odys-
sey Infrared Imaging System (LI-COR Biotechnology). For pull-down assays, 
5 μg of puriﬁ  ed S-tagged Par-3 fragments were bound to S-protein agarose 
beads and incubated for 40 min at 4°C with lysates from COS cells over-
expressing LIMK1 or LIMK2. Bound proteins were eluted with SDS sample 
buffer, separated by SDS-PAGE, and detected by Western blotting.
For in vitro binding assays, 40 μg GST–LIMK2 ∆C or GST-Rac was 
incubated with 10 μg S-tagged Par-3 fragments immobilized on S-protein 
agarose beads in 300 μl of binding buffer (1% Triton X-100, 145 mM 
NaCl, 10 mM Tris-HCl, pH 7.4, 5 mM EDTA, 2 mM EGTA, 1 mM PMSF, 
and 1 mM dithiotreitol) for 1 h at 4°C. The beads were washed three times 
with binding buffer containing 500 mM NaCl and once with regular bind-
ing buffer without Triton X-100. Proteins bound to beads were analyzed by 
SDS-PAGE and Western blotting.
In vitro kinase assays
In vitro kinase assays were performed essentially as described previously 
(Sumi et al., 2001). Constructs expressing HA-tagged proteins were indi-
vidually transfected into COS cells. 40 h later, HA-tagged proteins were 
immunoprecipitated with an anti-HA antibody 12CA5 either alone or 
  together after combining the lysates. After extensive washing with lysis 
  buffer and kinase buffer, immunoprecipitates were incubated for 20 min 
at 30°C in 16 μl of kinase buffer containing 50 μM ATP, 5 μCi γ-[
32P]ATP 
(4,500 Ci/mmol; MP Biomedicals), and 6 μg GST-coﬁ  lin or GST-Rac1. 
The reactions were terminated by adding 4× SDS sample buffer followed 
by SDS-PAGE, Coomassie staining, and autoradiography.
Online supplemental material
Fig. S1 shows the effects of Par-3, occludin, and E-cadherin KD as well 
as Par-3/E-cadherin double KD on phospho-coﬁ   lin levels in MDCK cells 
(A−C). Par-3/Tiam1 double KD does not reduce phospho-coﬁ  lin levels (D).
It also shows that KD of coﬁ  lin alone does not disrupt tight junctions (E−G) 
and shows the effects of Tiam1 KD and coﬁ   lin S3A expression on TER 
establishment in Par-3–depleted MDCK cells (H). Fig. S2 shows that the 
kinase activity of LIMK2 is not required for its association with Par-3 (A) 
and that Par-3 does not associate with ROCK (B). It also shows that LIMK2 
KD promotes TER development in Par-3–depleted MDCK cells (C) and the 
actin organization during calcium switch in control and Par-3 KD cells (D). 
Fig. S3 shows the elevated levels of Thr505 phosphorylation on LIMK2 
in Par-3–depleted MDCK cells (A). It also shows that Par-3 inhibits 
LIMK2 but not LIMK1 kinase activity in vitro (B) and that Pals1 does not 
inhibit LIMK2 activity (C). Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200510061/DC1.
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